Loading clinical trials...
Loading clinical trials...
This study will assess the pharmacokinetics of PXL770 after 4 weeks of treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Poxel SA
NCT05330923 · Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and more
NCT07518784 · MASLD, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), and more
NCT02815891 · Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis
NCT07237750 · Overweight and/or Obesity, Metabolic Syndrome, and more
NCT06523530 · Metabolic Dysfunction-Associated Steatotic Liver Disease, Nonalcoholic Fatty Liver, and more
High Point Clinical Trials Center
High Point, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions